Hudson Bay Capital Management LP Sarepta Therapeutics, Inc. Transaction History

Hudson Bay Capital Management LP

$25.3 Billion
Q3 2025

A detailed history of Hudson Bay Capital Management LP transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Hudson Bay Capital Management LP holds 50,000 shares of SRPT stock, worth $940,499. This represents 0.0% of its overall portfolio holdings.

Number of Shares

50,000

Previous 50,000 -0.0%

Holding current value

$940,499

Previous $963,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	SELL	$11.93 - $21.97 $812,397 - $1.5 Million	-68,097 Reduced 25.4%	200,003 $3.85 Million
Q2 2025 Aug 14, 2025	BUY	$17.1 - $63.66 $1.16 Million - $4.32 Million	67,850 Added 33.88%	268,100 $4.58 Million
Q1 2025 May 14, 2025	BUY	$63.82 - $127.89 $8.63 Million - $17.3 Million	135,250 Added 208.08%	200,250 $12.8 Million
Q3 2024 Nov 13, 2024	BUY	$124.33 - $156.75 $7.15 Million - $9.01 Million	57,500 Added 766.67%	65,000 $8.12 Million
Q2 2024 Aug 14, 2024	BUY	$113.33 - $163.85 $849,975 - $1.23 Million	7,500 New	7,500 $1.19 Million

Q4 2023 Feb 14, 2024	BUY	$67.31 - $124.76 $2.91 Million - $5.39 Million	43,208 Added 96.02%	88,208 $8.51 Million
Q3 2023 Nov 14, 2023	BUY	$102.5 - $123.59 $4.61 Million - $5.56 Million	45,000 New	45,000 $5.45 Million
Q4 2022 Feb 14, 2023	SELL	$100.86 - $132.13 $12.4 Million - $16.2 Million	-122,620 Reduced 72.13%	47,380 $6.14 Million
Q3 2022 Nov 14, 2022	SELL	$75.71 - $119.24 $1.32 Million - $2.09 Million	-17,500 Reduced 9.33%	170,000 $18.8 Million
Q2 2022 Aug 12, 2022	BUY	$62.69 - $88.44 $9.09 Million - $12.8 Million	145,000 Added 341.18%	187,500 $14.1 Million
Q1 2022 May 16, 2022	BUY	$63.15 - $90.42 $2.68 Million - $3.84 Million	42,500 New	42,500 $3.32 Million
Q3 2021 Nov 15, 2021	SELL	$65.97 - $92.48 $2.47 Million - $3.47 Million	-37,500 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$69.38 - $86.75 $659,110 - $824,125	9,500 Added 33.93%	37,500 $2.92 Million
Q1 2021 May 14, 2021	BUY	$72.25 - $168.95 $2.02 Million - $4.73 Million	28,000 New	28,000 $2.09 Million
Q4 2019 Feb 12, 2020	SELL	$76.53 - $135.58 $3.44 Million - $6.1 Million	-45,000 Closed	0 $0
Q3 2019 Nov 13, 2019	BUY	$72.81 - $156.91 $3.28 Million - $7.06 Million	45,000 New	45,000 $3.39 Million
Q1 2019 May 15, 2019	SELL	$106.67 - $151.68 $1.07 Million - $1.52 Million	-10,000 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$115.31 - $161.51 $1.15 Million - $1.62 Million	-10,000 Reduced 50.0%	10,000 $1.62 Million
Q2 2018 Aug 13, 2018	BUY	$71.74 - $153.69 $1.43 Million - $3.07 Million	20,000 New	20,000 $2.64 Million
Q1 2018 May 14, 2018	SELL	$54.02 - $82.27 $9.21 Million - $14 Million	-170,400 Closed	0 $0
Q4 2017 Feb 12, 2018	SELL	$47.64 - $56.75 $925,025 - $1.1 Million	-19,417 Reduced 10.23%	170,400 $9.48 Million
Q3 2017 Nov 13, 2017	BUY	$35.73 - $47.15 $6.78 Million - $8.95 Million	189,817	189,817 $8.61 Million

Others Institutions Holding SRPT

# of Institutions

406

Shares Held

83.7M

Call Options Held

5.27M

Put Options Held

5.94M

View Full List

About Sarepta Therapeutics, Inc.

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $1.65B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

More about SRPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hudson Bay Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Hudson Bay Capital Management LP with notifications on news.

Account

Hudson Bay Capital Management LP Sarepta Therapeutics, Inc. Transaction History